C WorldWide Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-75,890
Closed -$11.1M 119
2019
Q1
$11.1M Hold
75,890
0.14% 36
2018
Q4
$10.1M Hold
75,890
0.15% 40
2018
Q3
$14.5M Sell
75,890
-9,211
-11% -$1.69M 0.19% 32
2018
Q2
$14.2M Hold
85,101
0.2% 29
2018
Q1
$14.3M Sell
85,101
-9,985
-11% -$1.67M 0.22% 29
2017
Q4
$15.6M Hold
95,086
0.22% 30
2017
Q3
$19.5M Sell
95,086
-3,704
-4% -$861K 0.28% 30
2017
Q2
$24M Sell
98,790
-9,806
-9% -$2.3M 0.36% 27
2017
Q1
$25.9M Hold
108,596
0.44% 23
2016
Q4
$22.8M Sell
108,596
-8,946
-8% -$1.85M 0.44% 27
2016
Q3
$27.1M Hold
117,542
0.48% 26
2016
Q2
$27.2M Sell
117,542
-6,500
-5% -$1.5M 0.52% 24
2016
Q1
$33.2M Sell
124,042
-12,600
-9% -$3.61M 0.64% 22
2015
Q4
$42.7M Buy
136,642
+6,500
+5% +$1.94M 0.75% 20
2015
Q3
$35.4M Sell
130,142
-3,400
-3% -$1.04M 0.59% 21
2015
Q2
$40.5M Buy
133,542
+21,000
+19% +$6.26M 0.58% 21
2015
Q1
$33.5M Buy
112,542
+26,368
+31% +$7.52M 0.48% 25
2014
Q4
$22.2M Buy
86,174
+20,152
+31% +$5.04M 0.33% 25
2014
Q3
$15.9M Buy
+66,022
New +$14.8M 0.23% 34

Other funds holding AGN

C WorldWide Group's AGN Position: Q2 2019 in Review

C WorldWide Group sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 75,890 shares — an estimated $11.1M sold.

C WorldWide Group first reported a position in AGN in Q3 2014 and held it in 19 quarters. The position peaked at $42.7M in Q4 2015. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • C WorldWide Group reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 75,890 Allergan plc shares in Q2 2019, an estimated $11.1M.
  • C WorldWide Group first reported a position in Allergan plc in Q3 2014 and held it in 19 quarters.
  • C WorldWide Group's Allergan plc position peaked at $42.7M in Q4 2015.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.